HCM
EVH icon

Hollencrest Capital Management’s Evolent Health EVH Stock Holding History

Hollencrest Capital Management’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-2,000
Closed -$18.9K – 1152
2025
Q1 		$18.9K Sell
2,000
-34,000
-94% -$343K ﹤0.01% 684
2024
Q4 		$405K Buy
36,000
+7,500
+26% +$132K 0.02% 221
2024
Q3 		$806K Sell
28,500
-66,825
-70% -$1.72M 0.03% 166
2024
Q2 		$1.82M Buy
+95,325
New +$2.43M 0.08% 94
2023
Q1 		– Sell
-1,500
Closed -$42.1K – 1149
2022
Q4 		$42.1K Buy
+1,500
New +$43K 0.01% 486
2021
Q1 		– Sell
-43,000
Closed -$689K – 384
2020
Q4 		$689K Buy
43,000
+28,500
+197% +$377K 0.07% 144
2020
Q3 		$180K Buy
+14,500
New +$170K 0.02% 291

Other funds holding EVH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCM
Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $10.3B AUM 29.04% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $327M AUM 22.96% 1-Year Est. Return
RF
Rubicon Founders Nashville, Tennessee $196M AUM 53.12% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Hollencrest Capital Management's EVH Position: Q2 2025 in Review

Hollencrest Capital Management sold out of Evolent Health (EVH) in Q2 2025, closing a stake of 2,000 shares — an estimated $18.9K sold.

Hollencrest Capital Management first reported a position in EVH in Q3 2020 and held it in 7 quarters. The position peaked at $1.82M in Q2 2024. 221 funds tracked by Wall St. Rank hold EVH as of Q2 2025.

  • Hollencrest Capital Management reported no remaining Evolent Health position as of Q2 2025 after selling out during the quarter.
  • Hollencrest Capital Management sold 2,000 Evolent Health shares in Q2 2025, an estimated $18.9K.
  • Hollencrest Capital Management first reported a position in Evolent Health in Q3 2020 and held it in 7 quarters.
  • Hollencrest Capital Management's Evolent Health position peaked at $1.82M in Q2 2024.
  • 221 funds tracked by Wall St. Rank held Evolent Health as of Q2 2025.

Based on Hollencrest Capital Management's 13F filing for Q2 2025, filed 18 Aug 2025.